Powder: -20°C for 3 years | In solvent: -80°C for 1 year
KN-93 phosphate is a novel membrane-permeant synthetic inhibitor of purified neuronal CaMK-II with K i of 370 nM. KN-93 phosphate inhibits serum-induced fibroblast cell growth in a comparable dose-dependent fashion to its inhibition of CaMK-II activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 44.00 | |
5 mg | In stock | $ 98.00 | |
10 mg | In stock | $ 147.00 | |
25 mg | In stock | $ 297.00 | |
50 mg | In stock | $ 553.00 | |
100 mg | In stock | $ 798.00 | |
500 mg | In stock | $ 1,590.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 142.00 |
Description | KN-93 phosphate is a novel membrane-permeant synthetic inhibitor of purified neuronal CaMK-II with K i of 370 nM. KN-93 phosphate inhibits serum-induced fibroblast cell growth in a comparable dose-dependent fashion to its inhibition of CaMK-II activity. |
Targets&IC50 | CaMK II:0.37 μM(Ki) |
In vitro | Following a 2-day exposure to KN-93, 95% of cells were found to be halted in the G1 phase of the cell cycle, a condition that is reversible as evidenced by the progression of cells into the S and G2-M phases a day after cessation of KN-93 treatment. Additionally, KN-93 inhibits cell proliferation induced by basic fibroblast growth factor, platelet-derived growth factor-BB, and epidermal growth factor in NIH 3T3 fibroblasts. It also counteracts the activity of H+, K+-ATPase and disrupts the proton gradient across gastric membrane vesicles, ultimately leading to a decrease in the luminal space volume. Moreover, at a concentration of 0.5 μM, KN-93 prevents the increase in left ventricular developed pressure during action potential prolongation and early afterdepolarizations, a phenomenon associated with a rise in Ca2+-independent CaM kinase activity, which is inhibited by pre-treatment with KN-93. |
Molecular Weight | 599.03 |
Formula | C26H32ClN2O8PS |
CAS No. | 1913269-12-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 93 mg/mL (155.3 mM)
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
H2O: 84 mg/mL (140.2 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
KN-93 Phosphate 1913269-12-1 Neuroscience CaMK KN 93 Phosphate KN93 Phosphate inhibitor inhibit